|
09-19-2010, 04:01 AM
|
|||
|
|||
Breast cancer drug Avastin in jeopardy of losing FDA approval
Women with advanced breast cancer don't have many options when it comes to targeted therapies. And now, they could soon lose one of the drugs in their arsenal against the disease.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA considers revoking approval of Avastin for advanced breast cancer | cancerfr | Breast Cancer | 0 | 08-17-2010 05:47 AM |
| As Data Go Against Avastin For Breast Cancer, FDA May Yank Approval | cancerfr | Extracranial Germ Cell Tumor | 0 | 08-17-2010 05:47 AM |
| Breast Cancer Drug Avastin Approval Withdrawn by FDA Panel | cancerfr | Breast Cancer | 0 | 07-22-2010 11:41 AM |
| Avastin approval to drive ovarian cancer drug market to $1.5 billion in 2018 | cancerfr | Ovarian Cancer | 0 | 04-07-2010 10:44 AM |
| Driven by the Approval and Rapid Uptake of Avastin, the Ovarian Cancer Drug Market Wi | cancerfr | Ovarian Cancer | 0 | 04-06-2010 09:15 PM |
Linear Mode
